Jesse Manunga, Hamza Hanif, Ellen Cravero, Sara Behmanesh, Elliot Stephenson, Ross M Clark, Nedaa Skeik, Mohammad Khasawneh, Kevin M Harris, Muhammad Ali Rana
{"title":"在开窗/分支支架移植时代,在没有定制设备的中心,开放与血管内复杂主动脉瘤修复的长期结果","authors":"Jesse Manunga, Hamza Hanif, Ellen Cravero, Sara Behmanesh, Elliot Stephenson, Ross M Clark, Nedaa Skeik, Mohammad Khasawneh, Kevin M Harris, Muhammad Ali Rana","doi":"10.1016/j.jvs.2025.08.045","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate and compare long-term outcomes of complex aortic aneurysms (cAAs) treated with open surgical repair (OR) or fenestrated/branched endovascular aneurysm repair (F/B-EVAR) between 2010 and 2023 at two institutions.</p><p><strong>Methods: </strong>This retrospective analysis compares outcomes of cAAs treated by OR vs. F/B-EVAR at two centers with no access to custom made fenestrated/branched devices. cAAs were defined as those requiring a suprarenal or higher clamp (OR) or unsuitable for commercially available infrarenal endografts. Primary endpoints were technical success and major adverse events (MAEs); secondary endpoints included target vessel patency, re-intervention rate, and long-term survival. MAEs encompassed in-hospital death, stroke, MI, paraplegia, renal insufficiency, dialysis, return to the operating room, target vessel loss, and conversion to open repair.</p><p><strong>Results: </strong>507 patients (OR: 157; F/B-EVAR: 350) underwent cAA repair. Majority were male (76%) with a median age of 74 (68, 80) years. F/B-EVAR patients were older and had higher comorbidities (p>0.001). For OR, clamp site was suprarenal/supramesenteric in 143 (91.1%) and intrathoracic in 14 (8.9%) patients with thoracoabdominal aneurysms. Complications were higher in patients requiring supraceliac clamp. In the F/B-EVAR group, 99.4% of 1,239 target vessels were successfully incorporated. The overall technical success rate was 97% (OR: 100%, F/B-EVAR: 96%). Thirty-day mortality was similar between groups (F/B-EVAR: 3.4%; OR: 1.9%, p=0.4), as were MAEs (F/B-EVAR: 20%; OR: 15%, p=0.12). However, operating room time, estimated blood loss, and ICU/hospital length of stay were higher in the OR group (p<0.001). Paraplegia occurred only in the F/B-EVAR group (1.7%), while pneumonia and wound complications were more common in the OR group (p<0.001). At a median follow-up of 60 months, actuarial 5-year survival was significantly higher in the OR group (89% vs. 85%, p=0.041). Long-term reintervention rates were similar (OR: 7.4%, F/B-EVAR: 5.1%, p=0.3).</p><p><strong>Conclusion: </strong>Both approaches are safe and effective for cAA repair. F/B-EVAR offers perioperative advantages - faster recovery and shorter ICU/hospital stays - while OR provides excellent long-term outcomes in selected patients. Comprehensive aortic centers should maintain expertise in both techniques to optimize individualized treatment.</p>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-Term Outcomes of Open versus Endovascular Complex Aortic Aneurysm Repairs at Centers Without Access to Custom Made Devices in the Fenestrated/Branched Stent-Graft Era.\",\"authors\":\"Jesse Manunga, Hamza Hanif, Ellen Cravero, Sara Behmanesh, Elliot Stephenson, Ross M Clark, Nedaa Skeik, Mohammad Khasawneh, Kevin M Harris, Muhammad Ali Rana\",\"doi\":\"10.1016/j.jvs.2025.08.045\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate and compare long-term outcomes of complex aortic aneurysms (cAAs) treated with open surgical repair (OR) or fenestrated/branched endovascular aneurysm repair (F/B-EVAR) between 2010 and 2023 at two institutions.</p><p><strong>Methods: </strong>This retrospective analysis compares outcomes of cAAs treated by OR vs. F/B-EVAR at two centers with no access to custom made fenestrated/branched devices. cAAs were defined as those requiring a suprarenal or higher clamp (OR) or unsuitable for commercially available infrarenal endografts. Primary endpoints were technical success and major adverse events (MAEs); secondary endpoints included target vessel patency, re-intervention rate, and long-term survival. MAEs encompassed in-hospital death, stroke, MI, paraplegia, renal insufficiency, dialysis, return to the operating room, target vessel loss, and conversion to open repair.</p><p><strong>Results: </strong>507 patients (OR: 157; F/B-EVAR: 350) underwent cAA repair. Majority were male (76%) with a median age of 74 (68, 80) years. F/B-EVAR patients were older and had higher comorbidities (p>0.001). For OR, clamp site was suprarenal/supramesenteric in 143 (91.1%) and intrathoracic in 14 (8.9%) patients with thoracoabdominal aneurysms. Complications were higher in patients requiring supraceliac clamp. In the F/B-EVAR group, 99.4% of 1,239 target vessels were successfully incorporated. The overall technical success rate was 97% (OR: 100%, F/B-EVAR: 96%). Thirty-day mortality was similar between groups (F/B-EVAR: 3.4%; OR: 1.9%, p=0.4), as were MAEs (F/B-EVAR: 20%; OR: 15%, p=0.12). However, operating room time, estimated blood loss, and ICU/hospital length of stay were higher in the OR group (p<0.001). Paraplegia occurred only in the F/B-EVAR group (1.7%), while pneumonia and wound complications were more common in the OR group (p<0.001). At a median follow-up of 60 months, actuarial 5-year survival was significantly higher in the OR group (89% vs. 85%, p=0.041). Long-term reintervention rates were similar (OR: 7.4%, F/B-EVAR: 5.1%, p=0.3).</p><p><strong>Conclusion: </strong>Both approaches are safe and effective for cAA repair. F/B-EVAR offers perioperative advantages - faster recovery and shorter ICU/hospital stays - while OR provides excellent long-term outcomes in selected patients. Comprehensive aortic centers should maintain expertise in both techniques to optimize individualized treatment.</p>\",\"PeriodicalId\":17475,\"journal\":{\"name\":\"Journal of Vascular Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Vascular Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jvs.2025.08.045\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jvs.2025.08.045","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
Long-Term Outcomes of Open versus Endovascular Complex Aortic Aneurysm Repairs at Centers Without Access to Custom Made Devices in the Fenestrated/Branched Stent-Graft Era.
Objective: To evaluate and compare long-term outcomes of complex aortic aneurysms (cAAs) treated with open surgical repair (OR) or fenestrated/branched endovascular aneurysm repair (F/B-EVAR) between 2010 and 2023 at two institutions.
Methods: This retrospective analysis compares outcomes of cAAs treated by OR vs. F/B-EVAR at two centers with no access to custom made fenestrated/branched devices. cAAs were defined as those requiring a suprarenal or higher clamp (OR) or unsuitable for commercially available infrarenal endografts. Primary endpoints were technical success and major adverse events (MAEs); secondary endpoints included target vessel patency, re-intervention rate, and long-term survival. MAEs encompassed in-hospital death, stroke, MI, paraplegia, renal insufficiency, dialysis, return to the operating room, target vessel loss, and conversion to open repair.
Results: 507 patients (OR: 157; F/B-EVAR: 350) underwent cAA repair. Majority were male (76%) with a median age of 74 (68, 80) years. F/B-EVAR patients were older and had higher comorbidities (p>0.001). For OR, clamp site was suprarenal/supramesenteric in 143 (91.1%) and intrathoracic in 14 (8.9%) patients with thoracoabdominal aneurysms. Complications were higher in patients requiring supraceliac clamp. In the F/B-EVAR group, 99.4% of 1,239 target vessels were successfully incorporated. The overall technical success rate was 97% (OR: 100%, F/B-EVAR: 96%). Thirty-day mortality was similar between groups (F/B-EVAR: 3.4%; OR: 1.9%, p=0.4), as were MAEs (F/B-EVAR: 20%; OR: 15%, p=0.12). However, operating room time, estimated blood loss, and ICU/hospital length of stay were higher in the OR group (p<0.001). Paraplegia occurred only in the F/B-EVAR group (1.7%), while pneumonia and wound complications were more common in the OR group (p<0.001). At a median follow-up of 60 months, actuarial 5-year survival was significantly higher in the OR group (89% vs. 85%, p=0.041). Long-term reintervention rates were similar (OR: 7.4%, F/B-EVAR: 5.1%, p=0.3).
Conclusion: Both approaches are safe and effective for cAA repair. F/B-EVAR offers perioperative advantages - faster recovery and shorter ICU/hospital stays - while OR provides excellent long-term outcomes in selected patients. Comprehensive aortic centers should maintain expertise in both techniques to optimize individualized treatment.
期刊介绍:
Journal of Vascular Surgery ® aims to be the premier international journal of medical, endovascular and surgical care of vascular diseases. It is dedicated to the science and art of vascular surgery and aims to improve the management of patients with vascular diseases by publishing relevant papers that report important medical advances, test new hypotheses, and address current controversies. To acheive this goal, the Journal will publish original clinical and laboratory studies, and reports and papers that comment on the social, economic, ethical, legal, and political factors, which relate to these aims. As the official publication of The Society for Vascular Surgery, the Journal will publish, after peer review, selected papers presented at the annual meeting of this organization and affiliated vascular societies, as well as original articles from members and non-members.